(Q40117235)

28722153

17 September 2017

title

Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment (English)

1 reference

17 September 2017

0 references

1 reference

David McCormick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Katharina Erb-Zohar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Zhanna D Kobalava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Hans-Peter Stobernack

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Holger Zimmermann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Helga Rübsamen-Schaeff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

18 July 2017

1 reference

28722153

British Journal of Clinical Pharmacology

17 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

2678-2686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

The Concise Guide to PHARMACOLOGY 2015/16: Transporters

5 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5698571

Erratum: A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

30 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBCP.13376

First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246

21 January 2018

1 reference

12 December 2020

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

12 December 2020

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

1 reference

12 December 2020

Cytomegalovirus in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1111/BCP.13376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28722153%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

28722153

1 reference